Lisa R. Gerak
Affiliations: | Pharmacology | University of Tennessee Health Science Center, Memphis, TN, United States |
Area:
Behavioral pharmacologyGoogle:
"Lisa Gerak"Mean distance: 17.14 (cluster 19) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gray RA, Heal DJ, Maguire DR, et al. (2022) Preclinical assessment of the abuse potential of purified botanical cannabidiol: self-administration, drug discrimination, and physical dependence. The Journal of Pharmacology and Experimental Therapeutics |
Gerak LR, France CP. (2021) Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys. Drug and Alcohol Dependence. 227: 108991 |
France CP, Ahern G, Averick S, et al. (2020) Countermeasures for preventing and treating opioid overdose. Clinical Pharmacology and Therapeutics |
Mada S, Gerak LR, Soyer A, et al. (2020) Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist. Psychopharmacology |
Maguire DR, Gerak LR, Sanchez JJ, et al. (2020) Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
Gerak LR, Gould GG, Daws LC, et al. (2020) Methocinnamox Produces Sustained Antagonism of the Antinociceptive Effects of Morphine and Persistent Decreases in [ 3 H]DAMGO Binding to μ Opioid Receptors in Rat Cortex The Faseb Journal. 34: 1-1 |
Maguire DR, Gerak LR, Disney A, et al. (2020) Effects of Acute and Repeated Methocinnamox Treatment on Fentanyl Self‐administration in Rhesus Monkeys The Faseb Journal. 34: 1-1 |
Maguire DR, Gerak LR, Cami-Kobeci G, et al. (2019) OREX-1019: a novel treatment for opioid use disorder and relapse prevention. The Journal of Pharmacology and Experimental Therapeutics |
Gerak LR, Maguire DR, France CP. (2019) Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors. Handbook of Experimental Pharmacology |
Gerak LR, Minervini V, Latham E, et al. (2019) Methocinnamox (MCAM) produces long-lasting antagonism of the behavioral effects of µ opioid receptor agonists but not prolonged precipitated withdrawal in rats. The Journal of Pharmacology and Experimental Therapeutics |